Literature DB >> 22895825

CDX-2 expression in malignant germ cell tumors of the testes, intratubular germ cell neoplasia, and normal seminiferous tubules.

Michael J Lee1, Adam P Vogt, Wayland Hsiao, Adeboye O Osunkoya.   

Abstract

CDX-2 is a caudal-type homeobox gene, encoding a transcription factor that plays an important role in proliferation and differentiation of intestinal epithelial cells. The utility of antibodies to CDX2 in the identification of adenocarcinomas of the gastrointestinal tract, particularly colorectal adenocarcinomas, in both primary and metastatic settings is well established. It is well-known that patients with testicular tumors may occasionally lack an obvious palpable mass. However, the expression of CDX2 in malignant germ cell tumors of the testes which have metastatic potential has not been previously studied in a large series. A tissue microarray was constructed from 52 malignant germ cell tumors of the testes including: 29 cases of classic seminoma, 8 cases of embryonal carcinoma, 8 cases of yolk sac tumor, 4 cases of malignant teratoma, 2 cases of choriocarcinoma, and 1 case of spermatocytic seminoma. Ten cases of intratubular germ cell neoplasia and seven cases of benign testicles with normal seminiferous tubules were also included in tissue microarray. Immunohistochemical stains for CDX2 was performed and analyzed. Only nuclear staining was considered positive. Positive expression of CDX2 was identified in 2/2 cases (100 %) of choriocarcinoma, 4/8 cases (50 %) of teratoma, 3/8 cases (38 %) of embryonal carcinoma, 3/8 cases (38 %) of yolk sac tumor, and 1/29 cases (3 %) of classic seminoma. CDX2 was negative in all cases of intratubular germ cell neoplasia, normal seminiferous tubules, and the only case of spermatocytic seminoma. The role of CDX-2 in the differentiation of intestinal/enteric epithelial cells may contribute to the formation of trophoblastic, glandular, villous, or cystic structures in germ cell tumors of the testes. This study suggests that the expression of CDX2 in a variety of malignant germ cell tumors of the testes may be a potential pitfall in metastatic tumors of unknown primary, which are thought to be of gastrointestinal/colorectal origin but are actually from a clinically occult testicular tumor.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22895825     DOI: 10.1007/s13277-012-0479-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  18 in total

1.  Expression of CDX2 in benign tissue and adenocarcinoma of the prostate.

Authors:  Mehsati Herawi; Angelo M De Marzo; Glen Kristiansen; Jonathan I Epstein
Journal:  Hum Pathol       Date:  2006-08-10       Impact factor: 3.466

2.  No organ left behind: tales of gut development and evolution.

Authors:  Didier Y R Stainier
Journal:  Science       Date:  2005-03-25       Impact factor: 47.728

3.  Solid pattern yolk sac tumor: a morphologic and immunohistochemical study of 52 cases.

Authors:  Chia-Sui Kao; Muhammad T Idrees; Robert H Young; Thomas M Ulbright
Journal:  Am J Surg Pathol       Date:  2012-03       Impact factor: 6.394

Review 4.  Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.

Authors:  Thomas M Ulbright
Journal:  Mod Pathol       Date:  2005-02       Impact factor: 7.842

Review 5.  Germ cell tumours.

Authors:  A Talerman
Journal:  Ann Pathol       Date:  1985       Impact factor: 0.407

6.  Expression of the intestinal transcription factor CDX2 in carcinoid tumors is a marker of midgut origin.

Authors:  Ian M Jaffee; Mahdis Rahmani; Maria G Singhal; Mamoun Younes
Journal:  Arch Pathol Lab Med       Date:  2006-10       Impact factor: 5.534

7.  CDX2 immunoreactivity in primary and metastatic ovarian mucinous tumours.

Authors:  Filippo Fraggetta; Giuseppe Pelosi; Alessia Cafici; Paolo Scollo; Paolo Nuciforo; Giuseppe Viale
Journal:  Virchows Arch       Date:  2003-10-24       Impact factor: 4.064

8.  Aberrant Cdx2 expression in endometrial lesions with squamous differentiation: important role of Cdx2 in squamous morula formation.

Authors:  Yoji Wani; Kenji Notohara; Makoto Saegusa; Choutatsu Tsukayama
Journal:  Hum Pathol       Date:  2008-05-20       Impact factor: 3.466

9.  Continuing increase in incidence of germ-cell testis cancer in young adults: experience from Connecticut, USA, 1935-1992.

Authors:  T Zheng; T R Holford; Z Ma; B A Ward; J Flannery; P Boyle
Journal:  Int J Cancer       Date:  1996-03-15       Impact factor: 7.396

10.  Comprehensive evaluation of CDX2 in invasive cervical adenocarcinomas: immunopositivity in the absence of overt colorectal morphology.

Authors:  Lisa M Sullivan; Mark E Smolkin; Henry F Frierson; Mary T Galgano
Journal:  Am J Surg Pathol       Date:  2008-11       Impact factor: 6.394

View more
  4 in total

1.  High-level expression of divergent endodermal lineage markers in gonadal and extra-gonadal yolk sac tumors.

Authors:  Hadi Shojaei; Hong Hong; Raymond W Redline
Journal:  Mod Pathol       Date:  2016-07-22       Impact factor: 7.842

2.  What Is Trophoblast? A Combination of Criteria Define Human First-Trimester Trophoblast.

Authors:  Cheryl Q E Lee; Lucy Gardner; Margherita Turco; Nancy Zhao; Matthew J Murray; Nicholas Coleman; Janet Rossant; Myriam Hemberger; Ashley Moffett
Journal:  Stem Cell Reports       Date:  2016-02-09       Impact factor: 7.765

3.  CDX2 immunostaining in primary and metastatic germ cell tumours of the testis.

Authors:  Fatma Oz Atalay; Berna Aytac Vuruskan; Hakan Vuruskan
Journal:  J Int Med Res       Date:  2016-11-11       Impact factor: 1.671

Review 4.  Complete remission of Cdx-2 positive primary testicular carcinoid tumor: 10-years follow-up and literature review.

Authors:  Eugen Widmeier; Hannah Füllgraf; Cornelius F Waller
Journal:  BMC Urol       Date:  2020-12-14       Impact factor: 2.264

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.